Health Trials

Autoimmune Intervention Mastery Course Study

ConditionsMultiple SclerosisClinically Isolated SyndromeFibromyalgiaPost Acute Sequelae of COVID-19Cancer in Remission With Persisting Fatigue
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-100
SponsorTerry L. Wahls

About this trial

The goal of this project is to critically evaluate the effectiveness of using an online program to improve diet and self-care in patients with multiple sclerosis (MS), clinically isolated syndrome (CIS), fibromyalgia, post acute sequela of covid, and cancer in remission with persisting fatigue.

Eligibility criteria

Qualifiers

self-reported multiple sclerosis

self-reported clinically isolated syndrome

Disqualifiers

None

Trial design

Treatments tested in this trial

  • Immediate Autoimmune Intervention Mastery Course (AIM)
  • Immediate Question and Answer sessions. (AIM Q and A sessions)
  • Delayed Autoimmune Intervention Mastery Course (delayed AIM course)
  • Delayed AIM Question and Answer sessions

Treatment groups

400 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Terry L. Wahls

Lead sponsor

University of Iowa

Sponsor institution

Source ClinicalTrials.gov